122 related articles for article (PubMed ID: 1274590)
21. Hepatotoxicity of methotrexate in the treatment of psoriasis.
Palmer HM
Practitioner; 1973 Sep; 211(263):324-8. PubMed ID: 4759241
[No Abstract] [Full Text] [Related]
22. Liver histology in rheumatoid arthritis patients receiving long-term methotrexate therapy. A prospective study with baseline and sequential biopsy samples.
Kremer JM; Lee RG; Tolman KG
Arthritis Rheum; 1989 Feb; 32(2):121-7. PubMed ID: 2920047
[TBL] [Abstract][Full Text] [Related]
23. Sequential liver biopsies during long-term methotrexate treatment for psoriasis: a reappraisal.
Boffa MJ; Chalmers RJ; Haboubi NY; Shomaf M; Mitchell DM
Br J Dermatol; 1995 Nov; 133(5):774-8. PubMed ID: 8555032
[TBL] [Abstract][Full Text] [Related]
24. Liver damage due to methotrexate in patients with psoriasis.
Dahl MG; Gregory MM; Scheuer PJ
Br Med J; 1971 Mar; 1(5750):625-30. PubMed ID: 5548839
[TBL] [Abstract][Full Text] [Related]
25. The value of a baseline liver biopsy prior to methotrexate treatment.
Dolan OM; Burrows D; Irvine A; Walsh M
Br J Dermatol; 1994 Dec; 131(6):891-4. PubMed ID: 7857846
[TBL] [Abstract][Full Text] [Related]
26. Liver biopsy in psoriasis.
Berge G; Lundquist A; Rorsman H; Akerman M
Br J Dermatol; 1970 Mar; 82(3):250-3. PubMed ID: 5441759
[No Abstract] [Full Text] [Related]
27. Galactose tolerance test and methotrexate-induced liver fibrosis and cirrhosis in patients with psoriasis.
Lenler-Petersen P; Søgård H; Thestrup-Pedersen K; Zachariae H
Acta Derm Venereol; 1982; 62(5):448-9. PubMed ID: 6183903
[TBL] [Abstract][Full Text] [Related]
28. Abnormalities of serum type III procollagen aminoterminal peptide in methotrexate-treated psoriatic patients with normal liver histology do not correlate with hepatic ultrastructural changes.
Oogarah PK; Rowland PL; Mitchell DM; Smith A; Chalmers RJ; Rowan B; Haboubi NY
Br J Dermatol; 1995 Oct; 133(4):512-8. PubMed ID: 7577576
[TBL] [Abstract][Full Text] [Related]
29. Role of non-alcoholic steatohepatitis in methotrexate-induced liver injury.
Langman G; Hall PM; Todd G
J Gastroenterol Hepatol; 2001 Dec; 16(12):1395-401. PubMed ID: 11851839
[TBL] [Abstract][Full Text] [Related]
30. Methotrexate induced liver cirrhosis. Studies including serial liver biopsies during continued treatment.
Zachariae H; Kragballe K; Søgaard H
Br J Dermatol; 1980 Apr; 102(4):407-12. PubMed ID: 7387883
[No Abstract] [Full Text] [Related]
31. The role of liver biopsies in psoriatic patients receiving long-term methotrexate treatment. Improvement in liver abnormalities after cessation of treatment.
Newman M; Auerbach R; Feiner H; Holzman RS; Shupack J; Migdal P; Culubret M; Camuto P; Tobias H
Arch Dermatol; 1989 Sep; 125(9):1218-24. PubMed ID: 2774597
[TBL] [Abstract][Full Text] [Related]
32. Methotrexate and liver function: a study of 13 psoriasis cases treated with different cumulative dosages.
Carneiro SC; Cássia FF; Lamy F; Chagas VL; Ramos-e-Silva M
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):25-9. PubMed ID: 18181969
[TBL] [Abstract][Full Text] [Related]
33. Psoriatic patients with chronic viral hepatitis do not have an increased risk of liver cirrhosis despite long-term methotrexate use: Real-world data from a nationwide cohort study in Taiwan.
Tang KT; Chen YM; Chang SN; Lin CH; Chen DY
J Am Acad Dermatol; 2018 Oct; 79(4):652-658. PubMed ID: 29753054
[TBL] [Abstract][Full Text] [Related]
34. Hepatotoxicity after long-term methotrexate therapy.
Reynolds FS; Lee WM
South Med J; 1986 May; 79(5):536-9. PubMed ID: 3704718
[TBL] [Abstract][Full Text] [Related]
35. Psoriasis and the liver: problems, causes and course.
Tula E; Ergun T; Seckin D; Ozgen Z; Avsar E
Australas J Dermatol; 2017 Aug; 58(3):194-199. PubMed ID: 26916498
[TBL] [Abstract][Full Text] [Related]
36. Serum aminoterminal propeptide of type III procollagen in psoriasis and psoriatic arthritis: relation to liver fibrosis and arthritis.
Zachariae H; Aslam HM; Bjerring P; Søgaard H; Zachariae E; Heickendorff L
J Am Acad Dermatol; 1991 Jul; 25(1 Pt 1):50-3. PubMed ID: 1880254
[TBL] [Abstract][Full Text] [Related]
37. Tempting liver fibrosis? Long-term psoriatic methotrexate therapy and heterozygous alpha1-antitrypsin deficiency.
Mathew J; Igbokwe UO; Morley N; Burt AD
Dermatology; 2006; 213(2):147-9. PubMed ID: 16902293
[TBL] [Abstract][Full Text] [Related]
38. The Australasian Psoriasis Collaboration view on methotrexate for psoriasis in the Australasian setting.
Rademaker M; Gupta M; Andrews M; Armour K; Baker C; Foley P; Gebauer K; George J; Rubel D; Sullivan J
Australas J Dermatol; 2017 Aug; 58(3):166-170. PubMed ID: 27402434
[TBL] [Abstract][Full Text] [Related]
39. The value of amino-terminal propeptide of type III procollagen in routine screening for methotrexate-induced liver fibrosis: a 10-year follow-up.
Zachariae H; Heickendorff L; Søgaard H
Br J Dermatol; 2001 Jan; 144(1):100-3. PubMed ID: 11167689
[TBL] [Abstract][Full Text] [Related]
40. Serum aminoterminal propeptide of type III procollagen. A non-invasive test for liver fibrogenesis in methotrexate-treated psoriatics.
Zachariae H; Søgaard H; Heickendorff L
Acta Derm Venereol; 1989; 69(3):241-4. PubMed ID: 2566230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
